HCM
AGN

Highlander Capital Management’s Allergan plc AGN Stock Holding History

Highlander Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-236
Closed -$42K – 643
2020
Q1 		$42K Buy
236
+50
+27% +$9.41K 0.03% 304
2019
Q4 		$36K Hold
186
– – 0.02% 339
2019
Q3 		$31K Sell
186
-4,850
-96% -$790K 0.02% 364
2019
Q2 		$843K Sell
5,036
-3,175
-39% -$440K 0.51% 58
2019
Q1 		$1.2M Buy
8,211
+4,050
+97% +$587K 0.74% 33
2018
Q4 		$557K Buy
4,161
+50
+1% +$8.2K 0.37% 72
2018
Q3 		$783K Sell
4,111
-25
-0.6% -$4.59K 0.44% 67
2018
Q2 		$690K Buy
4,136
+2,075
+101% +$333K 0.39% 74
2018
Q1 		$334K Buy
2,061
+50
+2% +$8.39K 0.2% 121
2017
Q4 		$329K Sell
2,011
-1,600
-44% -$287K 0.24% 112
2017
Q3 		$740K Sell
3,611
-475
-12% -$110K 0.58% 45
2017
Q2 		$997K Sell
4,086
-200
-5% -$47K 0.78% 28
2017
Q1 		$1.02M Buy
4,286
+475
+12% +$111K 0.84% 19
2016
Q4 		$800K Buy
3,811
+700
+23% +$145K 0.69% 31
2016
Q3 		$716K Sell
3,111
-250
-7% -$61.1K 0.64% 36
2016
Q2 		$777K Buy
3,361
+1,675
+99% +$386K 0.71% 29
2016
Q1 		$452K Buy
1,686
+150
+10% +$42.9K 0.42% 63
2015
Q4 		$480K Buy
1,536
+1,500
+4,167% +$447K 0.45% 58
2015
Q3 		$9K Hold
36
– – 0.01% 683
2015
Q2 		$11K Hold
36
– – 0.01% 642
2015
Q1 		$11K Sell
36
-44
-55% -$12.5K 0.01% 639
2014
Q4 		$21K Hold
80
– – 0.02% 553
2014
Q3 		$19.3K Hold
80
– – 0.02% 542
2014
Q2 		$17.8K Hold
80
– – 0.02% 551
2014
Q1 		$16.5K Hold
80
– – 0.02% 560
2013
Q4 		$13.4K Buy
+80
New +$12.5K 0.01% 594

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Highlander Capital Management's AGN Position: Q2 2020 in Review

Highlander Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 236 shares — an estimated $42K sold.

Highlander Capital Management first reported a position in AGN in Q4 2013 and held it in 26 quarters. The position peaked at $1.2M in Q1 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Highlander Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Highlander Capital Management sold 236 Allergan plc shares in Q2 2020, an estimated $42K.
  • Highlander Capital Management first reported a position in Allergan plc in Q4 2013 and held it in 26 quarters.
  • Highlander Capital Management's Allergan plc position peaked at $1.2M in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Highlander Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.